Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2025-08-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
半年报董事会决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 10th Board of Directors' 5th meeting of Northeast Pharmaceutical Group Co., Ltd. It specifically mentions the approval of the company's 2025 semi-annual report and summary, but does not contain the report itself. The document is short (632 characters) and refers readers to another announcement (2025-057) where the actual semi-annual report is disclosed. This fits the pattern of a Board/Management Information announcement about board meeting decisions rather than the report itself. Therefore, the correct classification is MANG (Board/Management Information).
2025-08-26 Chinese
半年报财务报表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2025. The presence of comprehensive financial data such as assets, liabilities, revenues, expenses, and cash flows for a half-year period indicates this is a financial report for a period shorter than a full fiscal year. The document is about 15,000 characters long, which is consistent with a substantive interim or quarterly report rather than a brief announcement or certification. There is no indication that this is an annual report, audit report, or other specific filing types. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
半年报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board (监事会) of Northeast Pharmaceutical Group Co., Ltd. It reports the approval of the company's 2025 semi-annual report and summary, referencing the actual report published elsewhere (announcement 2025-057). The document itself does not contain the financial data or the report but only the meeting decision regarding the report. The document length is short (612 characters) and serves as an announcement of the meeting resolution rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the meeting and report approval, not the report itself or a report publication announcement (RPA) since it does not explicitly state the report is attached or published here but references another announcement for the report.
2025-08-26 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2025 年半年度报告摘要" which translates to "2025 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, earnings per share, total assets, and shareholder information for the half-year period. The presence of comprehensive financial metrics and company operational data indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2897 characters, which is consistent with a summary but still contains substantive financial data. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
第十届董事会第四次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolution from the 10th Board of Directors' 4th meeting of Dongbei Pharmaceutical Group Co., Ltd. It details the appointment of a new board secretary and includes voting results. It does not contain financial data or detailed management discussion but is focused on board/management changes. The document is short (671 characters) and is a formal announcement of a board decision, fitting the category of Board/Management Information (MANG).
2025-07-28 Chinese
关于聘任董事会秘书的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new board secretary (董事会秘书) for the company 东北制药集团股份有限公司. It details the nomination, approval by the board, qualifications of the appointee, and contact information. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content clearly relates to a change in senior management or board-related personnel. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on this appointment, confirming it is not a full report or announcement of a report publication.
2025-07-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.